查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1560212

mRNA 疫苗市場報告：2030 年趨勢、預測與競爭分析

mRNA Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

mRNA 疫苗的趨勢和預測

到2030年，全球mRNA疫苗市場預計將達到268億美元，2024年至2030年的複合年成長率為8.3%。該市場的主要驅動力是對新疫苗和治療方法的需求激增以及患有慢性病和感染疾病的患者數量不斷增加。全球 mRNA 疫苗市場前景廣闊，醫院/診所市場和研究設施市場充滿機會。

Lucintel 預測，癌症免疫療法將在預測期內達到最高成長。

在這個市場中，由於疫苗接種方便、訓練有素的醫務人員以及先進的醫療基礎設施，越來越多的患者更喜歡醫院和診所，醫院和診所仍將是最大的細分市場。

由於人口中感染疾病的流行、強大的醫療基礎設施以及主要企業的存在，預計北美仍將是最大的地區。

mRNA疫苗市場新趨勢

mRNA 疫苗市場充滿活力，預計有許多趨勢將塑造其未來。其背景是技術的傳播、研究活動的活性化以及市場對先進疫苗技術的高需求。

  • 更廣泛的使用案例：除了 COVID-19 大流行之外，mRNA 技術還擴大了在開發疫苗和治療方法更多疾病（包括癌症和遺傳異常）方面的應用。這一趨勢是應對傳染病研究工作的延伸。
  • 標靶疫苗：根據每位患者的遺傳特徵製備個人化的mRNA疫苗是一種日益成長的趨勢，特別是在癌症治療中。這一趨勢旨在開發針對患者特定疾病標記的有效疫苗。
  • 增強的生產流程：生產過程的發展改進了 mRNA 疫苗的生產流程，使大規模生產變得更容易、更便宜。這一趨勢不僅對於最大限度地降低生產成本很重要，而且對於增加疫苗的使用也很重要。
  • 國際夥伴關係：國際合作正在加強 mRNA 技術的研究和開發工作。公司、國家和研究中心的聯合行動將促進創造新 mRNA 疫苗的創造力和速度。
  • 監管演變：隨著mRNA疫苗的使用越來越頻繁，監管機構也與時俱進，改革可能帶來潛在風險的結構性問題。這項進展還包括 mRNA 疫苗核准流程和安全要求的更新，旨在促進其正確融入醫療保健系統。

這些趨勢正在重塑 mRNA 疫苗市場，並透過擴大應用範圍、改進製造方法和吸引國際合作來擴大其開拓。這些趨勢正在鼓勵新的想法並改變 mRNA 疫苗的使用，以更有效的方式涵蓋更廣泛的疾病。

mRNA疫苗市場的最新趨勢

mRNA 疫苗市場的新興模式表明該領域取得了重大進展並擴大了其效用。像這樣開拓新興國家市場，無論從市場前景或是疫苗研發生產流程來說，都是大勢所趨。

  • 新疫苗的核准：最近，mRNA疫苗在治療病毒和惡性疾病方面的潛力已被認知並正在獲得核准。目前的這些進展似乎為 mRNA 技術的更廣泛應用奠定了基礎。
  • 技術創新：mRNA 技術正在取得進步，包括提高遞送系統穩定性以提高疫苗功效。一旦開發出來，mRNA 疫苗可能會變得更有效、更容易使用。
  • 增加投資：公共和私人投資者對加速 mRNA 疫苗開發的興趣日益濃厚。在這種情況下，將為反應過程和其他必要疫苗的生產以及提高生產能力提供財政援助。
  • 全球生產擴張：將透過建立更多設施來安排暫停 mRNA 疫苗生產設施的產能限制。建立此類設施是為了滿足不斷成長的全球疫苗市場並確保可靠的疫苗供應。
  • 研究合作：生物技術公司、大學和政府之間正在建立更緊密的聯繫，以加速基於 mRNA 技術的疫苗開發。這些特定營業單位的合作正在促進基於 mRNA 的疫苗開發的進展。

這些進步透過更廣泛的應用、改進的技術以及市場內更高水準的投資和商業活動，鞏固了 mRNA 疫苗市場領域的擴張。由於它是一個活躍且快速變化的行業領域，未來性充滿希望。

mRNA 疫苗市場的策略性成長機會

mRNA疫苗市場為各種類型的應用提供了成長的策略選擇。不斷評估新興市場的此類機會將有助於相關人員適應新趨勢並提高其市場佔有率。

  • 癌症免疫療法：這是一個快速發展的領域，正在開發 mRNA 疫苗來治療癌症。目前正在進行臨床試驗的個人化 mRNA 癌症疫苗的開發備受期待，並有可能改變傳統的癌症治療。
  • 感染疾病疫苗：mRNA 疫苗的其他市場包括流感和 RSV，提供了成長機會。該技術的多功能性使得能夠對新出現的感染疾病做出快速反應。
  • 聯合疫苗：有機會將針對不同疾病的mRNA疫苗聯合起來，具有巨大的策略性利益。透過此類策略可以提高疫苗的功效和易用性，從而增加其對更廣泛市場的吸引力。
  • 全球市場的擴大：mRNA疫苗的使用提供了更大的成長潛力，特別是在尚未開始使用現有疫苗技術的地區，例如開發中國家。我們需要優先考慮 mRNA 疫苗的民主化和降低價格。
  • 研發合作：在市場開拓，由於與其他國家聯合研發的好處得到更好的了解，新型mRNA疫苗的開發預計將快速成長。這種合作創造了一個共用資源和知識的平台，從而促進市場成長。

這些成長機會凸顯了針對各種健康狀況的 mRNA 疫苗的潛在應用和市場擴張。所有相關人員都可以利用這些機會，根據新趨勢加強疫苗市場的開拓。

mRNA疫苗市場的促進因素與挑戰

mRNA疫苗市場存在各種促進因素​​和挑戰，以及影響市場發展和成長的挑戰。了解這些因素對於正確駕馭市場非常重要。

推動 mRNA 疫苗市場的因素包括：

1.技術進步：隨著疫苗變得更加有效和安全，mRNA技術的新發展將繼續推動市場成長。輸送系統和穩定技術的改進正在提高疫苗的品質。

2. 支出增加：政府機構和非政府組織資金的增加刺激了mRNA疫苗的研究和開發。這筆資金將有助於開發其他候選疫苗並擴大生產規模。

3.不斷成長的疫苗市場：mRNA技術是開發各種治療性疫苗的通用方法。

4.有利的法規環境：法規環境的有利措施促進了mRNA疫苗的核准和使用。關於安全問題，我們也在考慮需要採取什麼措施以及需要多長時間。

5. 改善跨國交流：全球交流與合作使mRNA疫苗研發變得更容易。專家和材料的結合創造了新的想法並擴大了市場。

mRNA 疫苗市場面臨的挑戰包括：

1.生產成本高：mRNA疫苗的生產價格仍然較高，阻礙了疫苗的經濟可用性。提高生產效率是阻礙進一步市場滲透的因素之一。

2.一定的監管：隨著mRNA疫苗的新普及，mRNA疫苗開發者的相關性相當高，新興市場通常令人期待。

3.現有技術的可利用性：由於高成本和技術超越的矛盾，實現高成長可能存在障礙。然而，透過有效利用這些障礙，你可以有效地擴展你的範圍。

mRNA疫苗市場存在的促進因素和挑戰與技術進步狀況、投資模式和管理體制本身有很大關係，因為它們影響市場向某個方向的開拓。為了在這個行業中取得成功，必須解決這些問題並實現預期的市場目標。

mRNA 疫苗按市場

本研究按類型、應用、最終用途和地區對全球 mRNA 疫苗進行了預測。

mRNA疫苗市場的國家展望

全球主要市場的mRNA疫苗市場正在發生重大變化和發展。市場的成長機會和轉型是由技術發展、監管核准和擴大使用範圍等因素所驅動的。美國、中國、德國、印度和日本是引領這一趨勢的國家之一，它們都在以某種方式改進其 mRNA 疫苗技術。

  • 美國：美國mRNA 疫苗的新進展現在正在被設計者看到，包括用於其他疾病的應用，包括癌症和流感。該公司正在開發新的以 mRNA 為重點的補充疫苗和其他治療擴展資產。美國也正在考慮為疫苗無效的疾病的治療提供資金。
  • 中國 中國有幾家本土生技公司目前正在開發 mRNA COVID-19 疫苗和其他類型的感染疾病疫苗，其中包括 BioNTech 在中國的被授權者。中國政府正在透過資金和合作夥伴關係促進這一成長，目標是成為 mRNA 領域的全球領導者。
  • 德國 總部位於德國的 BioNTech 旨在進一步提高其在 mRNA 疫苗方面的研發能力，包括治療各種癌症和其他罕見疾病。我們也正在擴大我們的生產設施並參與有關 mRNA 研究方法和分銷的國際夥伴關係關係。
  • 印度 印度的目標是開發一種廉價的 mRNA 疫苗，以幫助控制當地的健康挑戰，特別是寒冷季節的 COVID-19 病毒株和流感。印度生物技術公司正在尋求國際合作夥伴，以增加 mRNA 疫苗的研究和製造。
  • 日本 日本的 mRNA 疫苗市場在疫苗配方和製造技術的新發展方面取得了進展。此外，日本公司正在研究mRNA癌症疫苗和罕見疾病疫苗，並試圖將其納入日本的醫療體系。

常問問題

Q.1 mRNA疫苗的市場規模有多大？

A1. 到 2030 年，全球 mRNA 疫苗市場預計將達到 268 億美元。

Q.2 mRNA疫苗市場的成長預測如何？

A2. 2024年至2030年，全球mRNA疫苗市場預計將以8.3%的複合年成長率成長。

Q.3 影響 mRNA 疫苗市場成長的關鍵促進因素有哪些？

A3.該市場的主要驅動力是對新疫苗和療法的需求激增以及慢性病和感染疾病患者數量的增加。

Q4.市場的主要細分市場是：

A4. mRNA疫苗市場的未來在醫院/診所市場和研究機構市場看來前景看好。

Q5.市場的主要企業是：

A5. 主要mRNA疫苗公司如下：

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計癌症免疫療法將在預測期內達到最高成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於人口中感染疾病的流行、強大的醫療基礎設施以及主要企業的存在，北美將繼續成為最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球mRNA疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球mRNA疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 全球 mRNA 疫苗市場（按類型）
    • 自擴增 mRNA 疫苗 (SAM)
    • 傳統非擴增 mRNA 疫苗
  • 全球 mRNA 疫苗市場（依應用）
    • 癌症免疫治療
    • 過敏耐受性
    • 治療性疫苗
  • 全球 mRNA 疫苗市場（依最終用途）
    • 醫院/診所
    • 實驗室
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球 mRNA 疫苗市場（按地區）
  • 北美mRNA疫苗市場
  • 歐洲mRNA疫苗市場
  • 亞太地區mRNA疫苗市場
  • 其他地區mRNA疫苗市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球 mRNA 疫苗市場的成長機會（按類型）
    • 全球 mRNA 疫苗市場成長機會（按應用）
    • 全球 mRNA 疫苗市場成長機會（依最終用途）
    • 全球 mRNA 疫苗市場成長機會（按地區）
  • 全球 mRNA 疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球mRNA疫苗市場產能擴張
    • 全球 mRNA 疫苗市場的併購和合資企業
    • 認證和許可

第7章主要企業概況

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo
簡介目錄

mRNA Vaccine Trends and Forecast

The future of the global mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets. The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Within this market, hospital & clinic will remain the largest segment due to growing patients preference for this facilities because of the convenient access to vaccinations, availability of trained medical personnel, and existence of advanced healthcare infrastructure.

North America will remain the largest region due to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Emerging Trends in the mRNA Vaccine Market

The mRNA vaccine market is dynamic and changing with many trends that are expected to influence the future of it. This is driven by the proliferation of technology, increased research activities and high market demand for advanced vaccine technologies.

  • Broader Use Cases: mRNA technology is extending its application in the development of vaccines and therapies for more diseases in addition to the COVID-19 pandemic, for instance, cancer and genetic anomalies. This trend is an extension of the research bean in addressing contagious diseases.
  • Target-Oriented Vaccines: There is an increasing trend toward the preparing individualized mRNA vaccines depending on the genetics of individual patients especially in the treatment of cancers. This trend seeks to achieve effective vaccines designed for specific disease markers in patients.
  • Enhanced Production Processes: The growth of the production processes is improving the mRNA vaccine production processes by making it easier and cheaper to produce on a larger scale. This trend is important in the enhancement of vaccine usage as well as the minimization of production costs.
  • International Partnerships: International outreach is enhancing mRNA technology research and development endeavors. Joint actions of companies, countries and research centers sponsor creativity and the speed of new mRNA vaccines creation.
  • Regulatory Evolution: As mRNA vaccines are used more often, regulators are moving with the time and reforming structural issues which may pose potential risk. This trend includes updating the approval procedures and even the requirements for safety of mRNA vaccines aimed at promoting their proper integration in health care systems.

These trends are reshaping the mRNA vaccine market and expanding its development by broadening the scope of application, enhancing the methods of production and attracting international collaboration. They are encouraging new ideas and transforming the utilization of mRNA vaccines to cover a broader spectrum of diseases in a more efficient manner.

Recent Developments in the mRNA Vaccine Market

Emerging patterns in the mRNA vaccine market signal remarkable progress in this field and its expanding utility. Such developments are the order of the day as far as the outlook of the market is concerned and even the flow of vaccine development and manufacture.

  • New Vaccine Approvals: Lately the potential of mRNA vaccines in treating viral and even malignant diseases is being recognized and approved which is broadening the market. These current activities seem to be providing a foundation toward wider utilization of the mRNA technology.
  • Technological Innovations: MRNA technology advancement's such as vaccine undergoing refinement delivery systems stability enhancing vaccines efficacy are being realized. These as they are developed shall make mRNA vaccines more effective and easy to use.
  • Increased Investment: There has been an upsurge in appetite from public and private investors to facilitate the furtherance of mRNA vaccines. In such cases funding such as these will assist in the reaction processes or in the making of other necessary vaccines and boosting manufacturing capacities.
  • Global Manufacturing Expansion: This halt in the production capacity restriction for manufacturing facilities of mRNA vaccines is sorted by the establishment of further such facilities. Such facilities are being set up to satisfy the increasing the global market for vaccines and also for ensuring reliable vaccine supplies.
  • Research Collaborations: Stronger links are forged between biotech companies and universities with the government allowing the faster development of vaccines based on the mRNA technology. The collaboration of these specific types of entities is fostering progress in mRNA-based vaccine development.

Such advances are consolidating the expansion of the mRNA vaccine market sector through broader scope applications, bettering of technology, and enhancing the levels of investment and business activities within the market. They represent an industry segment that is active and rapidly changing and therefore has great future prospects.

Strategic Growth Opportunities for mRNA Vaccine Market

The market for mRNA vaccines gives different types of applications good strategic options for growth. Always assessing markets for such opportunities can also help the stakeholders to take to new trends and develop their presence in the market.

  • Cancer Immunotherapy: This is a fast-growing area whereby mRNA vaccines are developed for treating cancer. There is great hope in the development of personalized mRNA cancer vaccines in clinical trials that may change the treatment of cancer as we know it.
  • Vaccines for Infectious Diseases: Other markets for mRNA vaccines include influenza and RSV which offer opportunities for growth. Thanks to the technology's versatility, it enables quick response to newly emerging infectious diseases.
  • Combination Vaccines: There is an opportunity to have combined mRNA vaccines which target various diseases which is an excellent strategic benefit. Vaccine effectiveness and user-friendliness can be improved by such a strategy increasing its appeal to wider markets.
  • Global Market Expansion: The use of mRNA vaccines especially in regions like the developing nations that have not begun the use of the current vaccine technologies offers a bigger potential for growth. Efforts aimed at democratizing and cheapening the mRNA vaccines need to be pursued as a priority.
  • Research and Development Collaboration: The market witnesses rapid growth from the development of new mRNA vaccines through a greater understanding of the benefits of joint R&D with other countries. These collaborations create a platform for sharing resources and knowledge which promotes growth in the market.

These growth opportunities underscore the possibility of the application of mRNA vaccines to target different health conditions and their extended market reach. These opportunities may be used by any stakeholder to enhance the development of the vaccine market with new trends.

mRNA Vaccine Market Driver and Challenges

The mRNA vaccine market facilitates various drivers, in addition to challenges, which affect how the market can develop and grow. It is important to grasp such factors to be able to maneuver within the market appropriately.

The factors responsible for driving the MRNA vaccine market include:

1. Technological Progress: New developments in mRNA technology continue to propel the growth of the market as the vaccine becomes more effective and safe. Improvements in delivery systems and stabilization techniques are enhancing the quality of the vaccines.

2. Increased spending: The mRNA vaccine research and development is being stimulated through the provision of many resources from governmental and non-governmental organizations. Money helps the creation of other candidates for vaccines and the increase of the production scale.

3. Growing Vaccines Market: There is growing market growth because there is a growing demand for vaccines for various illnesses including but not limited to COVID-19 and cancer. mRNA technology is a universal approach for the development of different therapeutic vaccines.

4. Favorable Regulatory Environment: The approval and use of mRNA vaccines are being made easier by favorable actions in the regulatory environment. They are also addressing the issue of safety which measures need to be in place and how long the processes should take.

5. Improved Cross-border Interactions: Global interactions and collaborations have brought the implementation of mRNA vaccines closer. Combining the experts and materials encourages new ideas and broadens the market scope.

Challenges in the mRNA vaccine market are:

1. High Cost of Manufacturing: The price for manufacturing mRNA vaccines is still relatively high and this hinders the economical accessibility of the vaccines. Increasing production efficacy remains one of the hurdles to further penetration into the market.

2. Certain Set of Regulations: Emerging fashions of mRNA vaccines ensure the relevance of mRNA vaccine developers to be rather high and emerging new markets are usually expected.

3. Existing or Absence of Technology: There could be barriers to the implementation of high growth due to high costs, and inconsistencies owing to the changes - technological transcendence. However, one is utterly aware of the benefits rendered by the use of these hindrances for the effective development of scope.

As the drivers and challenges present in the mRNA vaccine market affect the developments of the market towards a certain direction, these relate rather to the state of advancement in the technology, the patterns of investment, and the very regulatory regime. To succeed in the industry, it is imperative to deal with these issues to achieve the desired market goals.

List of mRNA Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mRNA vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mRNA vaccine companies profiled in this report include-

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo

mRNA Vaccine by Segment

The study includes a forecast for the global mRNA vaccine by type, application, end use, and region.

mRNA Vaccine Market by Type [Analysis by Value from 2018 to 2030]:

  • Self-Amplifying mRNA Vaccines (SAM)
  • Conventional Non-Amplifying mRNA Vaccines

mRNA Vaccine Market by Application [Analysis by Value from 2018 to 2030]:

  • Cancer Immunotherapy
  • Allergy Tolerization
  • Therapeutic Vaccines

mRNA Vaccine Market by End Use [Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Research Laboratories
  • Others

mRNA Vaccine Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the mRNA Vaccine Market

Significant changes and progress in the mRNA vaccine market have been experienced in the key markets around the world. Growth opportunities and transformations in the market are being driven by factors such as technological developments, approvals by regulatory authorities and increasing scopes of use. The United States, China, Germany, India and Japan are some of the countries leading these trends, with all of them improving the mRNA vaccine technology in one aspect or another.

  • United States: In the US, at the present time new developments of mRNA vaccines include the designers' inclusion of its application for additional diseases such as cancer and other illnesses including influenza. The company is developing its new mRNA-focused replenishment vaccines and other treatment expansion assets. The United States is also considering funding against disease treatment where vaccine measures would not be effective
  • China: There are several local bio-tech companies in China, including BioNTech's Chinese licensee, which are now developing mRNA COVID-19 vaccines and other types of Infectious disease vaccines. The Chinese government has been promoting this growth with funds and collaborations, with the objective of dominating the mRNA sector globally.
  • Germany: With BioNTech headquartered in Germany, the country has made it a goal to further its mRNA vaccine R&D capabilities so as to include treatment for different cancers and other rare diseases. The country is also boosting its manufacturing facilities and participating in international partnerships regarding mRNA research methods and distribution practices.
  • India: In India, the objectives are to create cheap mRNA vaccines which would help control the local health challenges, especially COVID-19 strains and flu during cold seasons. Indian biotech companies are looking for international partners to strengthen the efforts towards the research and manufacturing of mRNA vaccines.
  • Japan: The Japanese market for mRNA vaccines has recorded progress with regard to new developments in vaccine formulations and production technologies. In addition, Japanese companies are looking into mRNA cancer vaccines and rare disease vaccines and incorporating them into the health care system in Japan.

Features of the Global mRNA Vaccine Market

Market Size Estimates: mRNA vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: mRNA vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: mRNA vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the mRNA vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mRNA vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What is the mRNA vaccine market size?

Answer: The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030.

Q.2 What is the growth forecast for mRNA vaccine market?

Answer: The global mRNA vaccine market is expected to grow with a CAGR of 8.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mRNA vaccine market?

Answer: The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

Q4. What are the major segments for mRNA vaccine market?

Answer: The future of the mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets.

Q5. Who are the key mRNA vaccine market companies?

Answer: Some of the key mRNA vaccine companies are as follows:

  • Pfizer
  • Moderna
  • BioNTech
  • GlaxoSmithKline
  • Daiichi Sankyo

Q6. Which mRNA vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Q7. In mRNA vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the mRNA vaccine market by type (self-amplifying mRNA vaccines (SAM) and conventional non-amplifying mRNA vaccines), application (cancer immunotherapy, allergy tolerization, and therapeutic vaccines), end use (hospitals & clinics, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
  • Market Report

Table of Contents

1. Executive Summary

2. Global mRNA Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global mRNA Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global mRNA Vaccine Market by Type
    • 3.3.1: Self-Amplifying mRNA Vaccines (SAM)
    • 3.3.2: Conventional Non-Amplifying mRNA Vaccines
  • 3.4: Global mRNA Vaccine Market by Application
    • 3.4.1: Cancer Immunotherapy
    • 3.4.2: Allergy Tolerization
    • 3.4.3: Therapeutic Vaccines
  • 3.5: Global mRNA Vaccine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Research Laboratories
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global mRNA Vaccine Market by Region
  • 4.2: North American mRNA Vaccine Market
    • 4.2.1: North American mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.2.2: North American mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
  • 4.3: European mRNA Vaccine Market
    • 4.3.1: European mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.3.2: European mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
  • 4.4: APAC mRNA Vaccine Market
    • 4.4.1: APAC mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.4.2: APAC mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
  • 4.5: ROW mRNA Vaccine Market
    • 4.5.1: ROW mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
    • 4.5.2: ROW mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global mRNA Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global mRNA Vaccine Market by Application
    • 6.1.3: Growth Opportunities for the Global mRNA Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global mRNA Vaccine Market by Region
  • 6.2: Emerging Trends in the Global mRNA Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global mRNA Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global mRNA Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Moderna
  • 7.3: BioNTech
  • 7.4: GlaxoSmithKline
  • 7.5: Daiichi Sankyo